Gland PharmaShare price target & analyst calls
₹3,079.1-71.50 (-2.27%)
Avg 1-year target
6 of 8 long-term calls BUY₹3,201.884.0% above today's price
Gland Pharma's average 1-year share price target is ₹3,201.88, the average of 8 advisors' latest targets. Targets range from ₹2,125 to ₹4,200.
Latest: Nomura India Research ₹3,750 · 7 Oct 2026
13
11 BUY · 2 SELL, all horizons
8
with an active 1Y target
39%
15 of 38 closed calls hit
51
all horizons, open and closed
Watch GLAND for new buy/sell callsGet alertsSee 54 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips · page 2 of 2
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- DRREDDYDr. Reddy's Laboratories Limited₹1,344+13.9% · 17 calls
- CIPLACipla Ltd.₹1,501+14.8% · 16 calls
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,226+26.5% · 15 calls
- BIOCONBiocon Ltd₹485+38.6% · 12 calls
- LUPINLupin Limited₹2,576+33.0% · 12 calls
- GLAND· this stockGland Pharma Limited₹3,202+4.0% · 8 calls
Showing 51–51 of 51